<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04853394</url>
  </required_header>
  <id_info>
    <org_study_id>2020-0795</org_study_id>
    <secondary_id>R01DA050464</secondary_id>
    <nct_id>NCT04853394</nct_id>
  </id_info>
  <brief_title>Tajik Migrant Health Education Study</brief_title>
  <official_title>MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prisma Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the efficacy of a peer-education prevention intervention to reduce risky&#xD;
      drug, alcohol, and sexual behaviors among male Tajik labor migrants who inject drugs (MWID)&#xD;
      while working in Moscow. The peer educator intervention will be compared to a health&#xD;
      education control intervention. Each intervention consists of 5 weekly 2-hour small group&#xD;
      sessions. Follow-up assessments will be conducted at 3, 6, 9, and 12 months after the&#xD;
      intervention. It is hypothesized that, compared to MWID who receive the health education&#xD;
      control intervention, those who receive the peer educator intervention will have a greater&#xD;
      reduction in the frequency of risk behaviors. Similar effects are expected for network&#xD;
      members of intervention participants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will recruit male Tajik migrants who inject drugs from 12 different sites&#xD;
      in Moscow, including bazaars and other work sites. In both study arms, the recruited men&#xD;
      (index participants) will be required to recruit two eligible MWID peers for interviews prior&#xD;
      to being interviewed themselves. Participants will be randomly assigned to either the peer&#xD;
      educator intervention program or the health education intervention program. After&#xD;
      peer-recruited network members are enrolled and interviewed, the index participant will&#xD;
      participate in the peer educator training or the control group activities. All participants&#xD;
      and recruited network members will then be followed and re-interviewed at 3-month intervals&#xD;
      for one year to assess changes in risky drug, alcohol, and sexual behaviors due to&#xD;
      intervention participation and through diffusion to network members. The investigators will&#xD;
      also collect data from voluntary HIV and HCV testing conducted at 6 months (HCV only) and at&#xD;
      12 months (HIV and HCV) post-intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 19, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>syringe sharing</measure>
    <time_frame>3 months</time_frame>
    <description>frequency of injecting with a previously used syringe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sex without condom</measure>
    <time_frame>3 months</time_frame>
    <description>frequency of vaginal or anal sex without a condom in the past 3 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>alcohol use</measure>
    <time_frame>30 days</time_frame>
    <description>Number of days drinking alcohol in past month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HIV infection</measure>
    <time_frame>12 months</time_frame>
    <description>incident HIV infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hepatitis C infection</measure>
    <time_frame>12 months</time_frame>
    <description>incident HCV infection</description>
  </secondary_outcome>
  <other_outcome>
    <measure>injection equipment sharing</measure>
    <time_frame>3 months</time_frame>
    <description>frequency of using shared injection equipment</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">420</enrollment>
  <condition>HIV Infections</condition>
  <condition>Hepatitis C</condition>
  <condition>Risky Health Behavior</condition>
  <condition>Risk Reduction Behavior</condition>
  <arm_group>
    <arm_group_label>MASLIHAT peer education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A peer educator prevention intervention program consisting of five weekly 2-hour small group sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TANSIHAT health education</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>A health education program consisting of five weekly 2-hour sessions small group sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>MASLIHAT</intervention_name>
    <description>peer educator intervention</description>
    <arm_group_label>MASLIHAT peer education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TANSIHAT</intervention_name>
    <description>health education intervention</description>
    <arm_group_label>TANSIHAT health education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult Tajik man&#xD;
&#xD;
          -  injected drugs in past 30 days&#xD;
&#xD;
          -  living and working as migrant laborer in Moscow&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  does not intend to stay in Moscow for the next 12 months&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary E Mackesy-Amiti, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonbek Jonbekov, B.A.</last_name>
    <phone>+992 935676565</phone>
    <email>jonbek@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mahbat Bakhromov, M.D.</last_name>
    <phone>+992 935676565</phone>
    <email>mahbat.bahromov@akdn.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>PRISMA Research Center</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonbek Jonbekov</last_name>
      <phone>+992 935676565</phone>
      <email>jonbek@mail.ru</email>
    </contact>
    <investigator>
      <last_name>Mahbat Bahromov, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 16, 2021</study_first_submitted>
  <study_first_submitted_qc>April 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Mary Ellen Mackesy-Amiti</investigator_full_name>
    <investigator_title>Research Associate Professor</investigator_title>
  </responsible_party>
  <keyword>injection drug use</keyword>
  <keyword>migrant workers</keyword>
  <keyword>risk behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The final data will be shared by depositing it in a public data repository. The final dataset will include self-reported sociodemographic characteristics, HIV transmission knowledge and risk awareness, sexual partners and risk behavior, illicit drug use and injection risk behavior, prevention self-efficacy, and injection drug use network interactions at 5 time points, and HIV and HCV test results at 2 time points. No identifying information will be included in the final dataset.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>The data will be made available upon study completion.</ipd_time_frame>
    <ipd_access_criteria>Access will be provided upon request with a description of the intended use.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

